Bacteriophage Therapy in Patients With Prosthetic Joint Infections Who Previously Failed Surgery for PJI (ACTIVE2)

Overview

About this study

The purpose of this study is to evaluate bacteriophage therapy + DAIR  in patients with chronic prosthetic joint infections. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Males or females, ≥ 18 years of age.
  • Recurrent Prosthetic Joint Infection (PJI) of the knee or hip.
  • History of one failed previous surgery for PJI.
  • Female patients of childbearing potential who agree to use contraception.
  • Confirmed phage match.
  • No anticipated need for long-term antibiotics.

Exclusion Criteria:

  • Soft tissue defect requiring reconstruction.
  • Hardware misalignment.
  • Additional orthopedic hardware in connection with the infected prosthesis.
  • Active infection (other than PJI) requiring long term antibiotics.
  • Unable to tolerate SAT.
  • Septic shock or hemodynamic instability.
  • Chronic kidney disease.
  • Liver disease.
  • Decompensated heart failure.
  • Positive drug screen.
  • Receiving chemotherapy.
  • Immunocompromised.
  • Treatment with antiviral medication within 2 weeks prior to randomization.
  • Currently participating in another clinical trial.
  • Known phage allergy.
  • Pregnant/ breast feeding.
  • Lack of capacity to consent.

Eligibility last updated 4/6/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Gina Suh, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20549450

Mayo Clinic Footer